{"id":1057,"date":"2026-09-30T12:08:13","date_gmt":"2026-09-30T06:38:13","guid":{"rendered":"https:\/\/www.wittytrades.com\/market-news\/alkem-share-price-today-2026-09-30\/"},"modified":"2026-10-05T20:38:02","modified_gmt":"2026-10-05T15:08:02","slug":"alkem-share-price-today-2026-09-30","status":"publish","type":"post","link":"https:\/\/www.wittytrades.com\/market-news\/alkem-share-price-today-2026-09-30\/","title":{"rendered":"Why Alkem Laboratories Shares Fell 1.65% Today: Sector Trends | 30 September 2026"},"content":{"rendered":"<style id=\"wt-article-style-v4\">:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) { color:#30475c; font-size:16px; line-height:1.65; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::before, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::after { box-sizing:border-box; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-copy { font-size:16px !important; line-height:1.65 !important; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-prose .wt-copy { margin-bottom:15px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-market-date { font-size:13px !important; line-height:1.55; color:#566b80; background:#f2f6f9; border:1px solid #dde6ec; border-left:4px solid #2e7db2; border-radius:6px; padding:8px 11px; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { display:grid; grid-template-columns:repeat(6,minmax(0,1fr)); gap:7px; margin:8px 0 16px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:10px !important; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:first-child { font-size:11px !important; line-height:1.45; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child { font-size:14px !important; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px 16px; min-width:0; overflow-wrap:anywhere; margin:14px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-title { font-size:16px; font-weight:800; line-height:1.45; color:#17324d; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-date { font-size:13px; line-height:1.5; color:#566b80; margin-bottom:9px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body { font-size:16px; line-height:1.6; color:#34495d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body .wt-copy:last-child { margin-bottom:0 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { display:grid; grid-template-columns:repeat(2,minmax(0,1fr)); gap:12px; margin:12px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > .wt-card { margin:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > :only-child { grid-column:1 \/ -1; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(3,minmax(0,1fr)); margin:10px 0 12px; gap:10px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-metric { background:#fff; border:1px solid #e1e8ef; border-radius:8px; padding:10px 12px; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-label { display:block; font-size:12px; font-weight:700; color:#566b80; line-height:1.5; margin-bottom:3px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-value { font-size:18px; font-weight:800; line-height:1.45; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-note { display:block; font-size:13px; color:#566b80; line-height:1.55; margin-top:4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source-note { margin:9px 0 4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source { display:inline-block; font-size:13px; line-height:1.5; margin-top:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { display:grid; grid-template-columns:2fr 1fr 1.2fr 1.2fr; gap:14px; padding:12px 0; border-bottom:1px solid #c9dbef; align-items:start; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row:last-of-type { border-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row strong { font-size:15px; line-height:1.5; display:block; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div { min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds { grid-template-columns:repeat(3,minmax(0,1fr)); margin:12px 0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card { padding:12px; background:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title { font-size:14px; font-weight:700; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:14px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-brokerage { grid-template-columns:1fr; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts { display:flex; flex-wrap:wrap; gap:14px 28px; margin:7px 0 12px; padding-bottom:10px; border-bottom:1px solid #cbd8ea; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts strong { font-size:16px; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list { font-size:16px !important; line-height:1.65; margin:0 0 12px; padding-left:20px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list li { margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card { background:#f7fbff !important; border-color:#cfe1f2 !important; border-left-color:#2e7db2 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card-title { color:#1f4d70; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-list { margin-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card { background:#f5fbfd !important; border-color:#c9d9e7 !important; border-left:5px solid #1f7b92 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-title { color:#174c5d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-body > strong { display:block; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:18px 19px; margin:22px 0; border-radius:13px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:19px; font-weight:800; line-height:1.4; margin-bottom:7px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow { background:linear-gradient(135deg,#ffe873,#ffd64a); border:1px solid #e3b600; box-shadow:0 8px 18px rgba(59,48,0,.09); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-title { color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-copy { color:#27364b !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark { background:#10233f; box-shadow:0 9px 22px rgba(16,35,63,.18); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-title { color:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-copy { color:#dce6f1 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-copy { font-size:16px !important; line-height:1.6; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-button { display:inline-block; background:#10233f; color:#fff !important; padding:10px 17px; border-radius:7px; text-decoration:none !important; font-size:15px; font-weight:800; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-button { background:#ffe36e; color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-faq h3 { color:#173b58 !important; font-size:17px !important; line-height:1.45; margin:18px 0 6px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) > p:last-child { font-size:13px; line-height:1.55; color:#606b78; border-top:1px solid #e1e7ef; padding-top:13px; margin-top:16px; }\n@media (max-width:960px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(3,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:1.7fr 1fr 1.2fr 1.2fr; gap:10px; }\n}\n@media (max-width:650px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { grid-template-columns:1fr; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(2,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:repeat(2,minmax(0,1fr)); gap:10px 14px; padding:12px 0; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-person, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div:last-child { grid-column:1 \/ -1; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:17px 15px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:18px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:9px !important; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:15px; }\n}\n@media (max-width:420px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(2,minmax(0,1fr)); }\n}<\/p>\n<p>:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div {border:1px solid #dde6ee;border-radius:8px;background:#f9fbfd;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child {font-weight:800;color:#17324d;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) h2 {font-size:24px !important;line-height:1.35 !important;margin:28px 0 14px !important;color:#173b58;}\n<\/style>\n<div class=\"wt-article-v4\" data-article-version=\"4\">\n<p class=\"wt-market-date\"><strong>NSE: ALKEM<\/strong> \u00b7 30 September 2026 \u00b7 Dated market coverage<\/p>\n<div class=\"wt-price-strip\">\n<div>\n<div>Price<\/div>\n<div>\u20b95,163.50<\/div>\n<\/div>\n<div>\n<div>Change<\/div>\n<div>-1.65%<\/div>\n<\/div>\n<div>\n<div>High \/ Low<\/div>\n<div>\u20b95,276.00 \/ \u20b95,135.00<\/div>\n<\/div>\n<div>\n<div>Prev. Close<\/div>\n<div>\u20b95,250.00<\/div>\n<\/div>\n<div>\n<div>Volume<\/div>\n<div>142,787<\/div>\n<\/div>\n<div>\n<div>Price as of<\/div>\n<div>30 Sep 2026 \u2022 03:15 PM IST<\/div>\n<\/div>\n<\/div>\n<div style=\"background:#f7fbff;border:1px solid #cfe1f2;border-left:5px solid #2e7db2;border-radius:10px;padding:15px 17px;margin:14px 0 18px;\" class=\"wt-card\">\n<div style=\"font-weight:900;color:#1f4d70;margin-bottom:7px;\" class=\"wt-card-title\">Key Takeaways<\/div>\n<ul style=\"margin:0;padding-left:18px;\">\n<li>The stock is -1.65% at \u20b95,163.50.<\/li>\n<li><strong>Likely reason:<\/strong>Sector-led pullback aligned with broader pharma weakness <\/li>\n<li>Approximate traded value is<strong>\u20b973.73 crore<\/strong>. <\/li>\n<li>It is -12.98% from its 52-week high and +2.23% from its 52-week low.<\/li>\n<li>The stock is being compared with<strong>Nifty Pharma<\/strong>alongside the Nifty 50. <\/li>\n<\/ul><\/div>\n<h2>Why Is Alkem Laboratories Share Price Falling 1.65% Today?<\/h2>\n<p class=\"wt-copy\">Latest NSE EOD report: 2026-09-29. Today&#8217;s Volume: 142,787; 5-Day Avg. Volume: 137,380; 20-Day Avg. Volume: 144,398; Volume vs 20-Day Avg.: 0.99x; Delivery Quantity: 126,663; Delivery %: 51.82%; Number of Trades: 36,626.<\/p>\n<div class=\"wt-prose\">\n<p class=\"wt-copy\">Alkem Laboratories (ALKEM) traded lower on September 30, 2026, dropping 1.65% to close at \u20b95,163.50. The stock opened at \u20b95,245.00, touched a day&#8217;s high of \u20b95,276.00, and slipped to an intraday low of \u20b95,135.00. Trading volume came in at 142,787 shares, remaining closely aligned with its 5-day and 20-day averages, indicating measured participation rather than panic selling.<\/p>\n<p class=\"wt-copy\">The broader market and pharmaceutical segment experienced downward pressure during the session. The Nifty index declined 0.42%, while the Nifty Pharma sector index fell more sharply by 1.84%, reflecting broader weakness across healthcare stocks. Alkem&#8217;s pullback is largely consistent with this prevailing sector-wide corrective trend rather than an isolated shock.<\/p>\n<p class=\"wt-copy\">Company developments over the preceding weeks included product rollouts such as the launch of NeuCeno for partial-onset seizures and Renocia Exo hair growth serum, alongside management changes including the resignation of its Chief Financial Officer. However, these announcements served as background context rather than immediate, direct catalysts for today&#8217;s intraday price correction.<\/p>\n<\/div>\n<div style=\"border:1px solid #c9d9e7;border-left:5px solid #1f7b92;border-radius:10px;background:#f5fbfd;padding:16px 18px;margin:16px 0 22px;\" class=\"wt-card\">\n<div style=\"gap:10px;align-items:center;flex-wrap:wrap;margin-bottom:7px;\" class=\"wt-card-title\">\n<div style=\"font-weight:900;color:#174c5d;\">Likely Reason for Today&#8217;s Move<\/div>\n<p> <span style=\"background:#fff1cf;color:#8a6116;padding:3px 8px;border-radius:999px;font-weight:900;text-transform:uppercase;\">medium confidence<\/span> <\/div>\n<div style=\"font-weight:850;color:#20384a;margin-bottom:7px;\">Sector-led pullback aligned with broader pharma weakness<\/div>\n<div style=\"\">Alkem&#8217;s 1.65% decline mirrors the broader Nifty Pharma sector downturn of 1.84%. In the absence of adverse company-specific disclosures today, the price movement is best attributed to prevailing sectoral headwinds.<\/div>\n<ul style=\"margin:10px 0 0;padding-left:18px;\">\n<li>Nifty Pharma sector dropped 1.84% during the session.<\/li>\n<li>Volume remained in line with short-term averages, showing normal liquidity without aggressive dumping.<\/li>\n<\/ul><\/div>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Ownership &amp; Transaction Activity<\/h2>\n<div class=\"wt-grid\" style=\"gap:16px;margin:14px 0 22px;width:100%;box-sizing:border-box;\">\n<div style=\"background:#fff5df;border:1px solid #ecd39e;border-left:5px solid #cc922c;border-radius:10px;padding:17px 19px;box-sizing:border-box;min-width:0;\" class=\"wt-card wt-card\">\n<div style=\"margin:0 0 10px;color:#8c6318;\" class=\"wt-card-title\">Promoter Pledge \/ Encumbrance<\/div>\n<p style=\"margin:0;\" class=\"wt-copy\">An NSE promoter pledge\/encumbrance filing was identified, but the available filing text could not be reduced reliably to a concise current pledge figure.<\/p>\n<p style=\"margin:10px 0 0;color:#7b673d;\" class=\"wt-copy\">Source: NSE corporate filing<\/p>\n<\/p><\/div>\n<div style=\"background:#f5f8fb;border:1px solid #d5e0ea;border-left:5px solid #6a849c;border-radius:10px;padding:17px 19px;box-sizing:border-box;min-width:0;\" class=\"wt-card wt-card\">\n<div style=\"margin:0 0 10px;color:#405d76;\" class=\"wt-card-title\">Recent Ownership \/ Shareholding Disclosure<\/div>\n<div style=\"\">Promoter shareholding disclosures and large block deals from earlier in the fiscal year reflect institutional rebalancing.<\/div>\n<ul style=\"margin:10px 0 0;padding-left:18px;\">\n<li>Promoters declared no encumbrance on shares for the financial year 2025-26 under SEBI Takeover Regulations.<\/li>\n<li>Large block deals in June 2026 saw entities such as Jayanti Sinha and Samprada &amp; Nanhamati Singh Family Trust divest stakes, while institutional buyers like ICICI Prudential Mutual Fund and HDFC Mutual Fund absorbed shares.<\/li>\n<\/ul>\n<p style=\"margin:10px 0 0;color:#647789;\" class=\"wt-copy\">Source: NSE corporate disclosure. Only factual ownership\/shareholding details extracted from the filing are shown.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<h2>Research &amp; Brokerage Views<\/h2>\n<div style=\"border:1px solid #cbd8ea;border-radius:12px;padding:14px;background:#f4f8fd;box-sizing:border-box;width:100%;\" class=\"wt-card\">\n<div style=\"width:100%;box-sizing:border-box;border:1px solid #cbd8ea;border-radius:10px;background:#fff;padding:14px 15px;margin-bottom:12px;\">\n<div class=\"wt-broker-row\" style=\"gap:10px;width:100%;box-sizing:border-box;align-items:stretch;\">\n<div style=\"background:#f4f8fd;border:1px solid #e1e8f1;border-radius:8px;padding:10px 12px;min-width:0;\">\n<div style=\"text-transform:uppercase;letter-spacing:.4px;color:#6d7d90;font-weight:800;margin-bottom:3px;\">Brokerage<\/div>\n<div style=\"font-weight:800;color:#21384f;\">Motilal Oswal<\/div>\n<\/p><\/div>\n<div style=\"background:#f4f8fd;border:1px solid #e1e8f1;border-radius:8px;padding:10px 12px;min-width:0;\">\n<div style=\"text-transform:uppercase;letter-spacing:.4px;color:#6d7d90;font-weight:800;margin-bottom:3px;\">View<\/div>\n<div style=\"font-weight:800;color:#21384f;\">Neutral<\/div>\n<\/p><\/div>\n<div style=\"background:#f4f8fd;border:1px solid #e1e8f1;border-radius:8px;padding:10px 12px;min-width:0;\">\n<div style=\"text-transform:uppercase;letter-spacing:.4px;color:#6d7d90;font-weight:800;margin-bottom:3px;\">Date<\/div>\n<div style=\"font-weight:800;color:#21384f;\">17 Aug 2026<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div style=\"margin-top:10px;background:#f8fafc;border:1px solid #e4eaf1;border-radius:8px;padding:11px 12px;\"><strong>Key rationale \/ reported context:<\/strong>Maintained a neutral stance following Q1 earnings despite a target price revision, balancing stable operational performance against valuation considerations. <\/div>\n<\/p><\/div>\n<p style=\"margin:8px 2px 0;\" class=\"wt-copy\"><em>Brokerage views are third-party opinions and are not WittyTrades recommendations.<\/em><\/p>\n<\/p><\/div>\n<h2>Historical Bulk \/ Block Deals<\/h2>\n<div style=\"border:1px solid #ead4c0;border-radius:12px;padding:17px;background:#fff7f0;box-sizing:border-box;width:100%;\" class=\"wt-card\">\n<div style=\"overflow-x:auto;\">\n<table style=\"width:100%;margin:0;\">\n<thead>\n<tr>\n<th>Type<\/th>\n<th>Date<\/th>\n<th>Party<\/th>\n<th>Side<\/th>\n<th>Qty<\/th>\n<th>Price<\/th>\n<th>Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Block<\/td>\n<td>02 Jun, 2026<\/td>\n<td>JAYANTI SINHA<\/td>\n<td>Sell<\/td>\n<td>12,38,220<\/td>\n<td>5,200<\/td>\n<td>\u20b9643.87 Cr<\/td>\n<\/tr>\n<tr>\n<td>Block<\/td>\n<td>02 Jun, 2026<\/td>\n<td>ICICI PRUDENTIAL MUTUAL FUND<\/td>\n<td>Buy<\/td>\n<td>9,03,527<\/td>\n<td>5,200<\/td>\n<td>\u20b9469.83 Cr<\/td>\n<\/tr>\n<tr>\n<td>Block<\/td>\n<td>02 Jun, 2026<\/td>\n<td>SAMPRADA&amp;NANHAMATI SINGH FAMILY TRUST<\/td>\n<td>Sell<\/td>\n<td>5,50,000<\/td>\n<td>5,200<\/td>\n<td>\u20b9286.00 Cr<\/td>\n<\/tr>\n<tr>\n<td>Block<\/td>\n<td>02 Jun, 2026<\/td>\n<td>HDFC MUTUAL FUND<\/td>\n<td>Buy<\/td>\n<td>5,09,615<\/td>\n<td>5,200<\/td>\n<td>\u20b9265.00 Cr<\/td>\n<\/tr>\n<tr>\n<td>Block<\/td>\n<td>02 Jun, 2026<\/td>\n<td>DSP MUTUAL FUND<\/td>\n<td>Buy<\/td>\n<td>86,538<\/td>\n<td>5,200<\/td>\n<td>\u20b945.00 Cr<\/td>\n<\/tr>\n<tr>\n<td>Block<\/td>\n<td>02 Jun, 2026<\/td>\n<td>SOCIETE GENERALE<\/td>\n<td>Buy<\/td>\n<td>48,090<\/td>\n<td>5,200<\/td>\n<td>\u20b925.01 Cr<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<p style=\"margin:10px 0 0;\" class=\"wt-copy\"><strong>Interpretation:<\/strong>Large institutional transactions can affect liquidity and short-term price behaviour, but should not be read on their own as a directional signal. <\/p>\n<\/p><\/div>\n<div class=\"witty-insight\">\n<h3>WittyTrades Data Insight<\/h3>\n<p class=\"wt-copy\"><strong>Price Position:<\/strong>The stock is around the middle of the day&#8217;s trading range. <\/p>\n<p class=\"wt-copy\"><strong>Move From Open:<\/strong>-1.55%. <\/p>\n<p class=\"wt-copy\"><strong>Intraday Range:<\/strong>2.69% of the previous close. <\/p>\n<p class=\"wt-copy\"><strong>5-Day Performance:<\/strong>-4.69%; <strong>20-Day Performance:<\/strong>-0.89%. <\/p>\n<\/p><\/div>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Latest Company Developments<\/h2>\n<div style=\"background:#fbfcfe;border:1px solid #e3e9f0;border-radius:12px;padding:14px;margin:12px 0 24px;width:100%;box-sizing:border-box;\" class=\"wt-card\">\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-weight:800;color:#17324d;margin-bottom:4px;\">CFO Resignation<\/div>\n<div style=\"color:#708090;margin-bottom:6px;\">24-Sep-2026<\/div>\n<div style=\"\">Alkem Laboratories notified the exchange regarding the resignation of its Chief Financial Officer. The company has initiated steps to ensure smooth continuity in financial operations while managing leadership transitions.<\/div>\n<div style=\"margin-top:8px;color:#4f5f6e;\"><strong>Why it matters:<\/strong>Changes in key managerial personnel require monitoring for potential execution or strategic shifts, though they rarely dictate single-session price movements. <\/div>\n<\/p><\/div>\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-weight:800;color:#17324d;margin-bottom:4px;\">Launch of NeuCeno for Seizures<\/div>\n<div style=\"color:#708090;margin-bottom:6px;\">16-Sep-2026<\/div>\n<div style=\"\">The company announced the commercial introduction of NeuCeno (cenobamate) in India, targeting the treatment of partial-onset seizures in adult patients. This expansion broadens Alkem&#8217;s specialty neurology footprint.<\/div>\n<div style=\"margin-top:8px;color:#4f5f6e;\"><strong>Why it matters:<\/strong>New product launches in high-margin specialty segments reinforce long-term domestic revenue diversification. <\/div>\n<\/p><\/div>\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-weight:800;color:#17324d;margin-bottom:4px;\">Introduction of Renocia Exo Hair Serum<\/div>\n<div style=\"color:#708090;margin-bottom:6px;\">08-Sep-2026<\/div>\n<div style=\"\">Alkem expanded its dermatology portfolio with the launch of Renocia Exo, marketed as India&#8217;s first patented Ginsenoside Exosome-based hair growth serum. The product targets the growing aesthetic and specialized skincare segment.<\/div>\n<div style=\"margin-top:8px;color:#4f5f6e;\"><strong>Why it matters:<\/strong>It highlights the company&#8217;s continuous product innovation within domestic consumer dermatology. <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"wt-grid\" style=\"gap:16px;margin:22px 0 24px;width:100%;box-sizing:border-box;\">\n<div style=\"border:1px solid #c8dfd9;border-radius:12px;padding:17px;background:#f0faf7;box-sizing:border-box;min-width:0;\" class=\"wt-card\"><\/div>\n<div style=\"border:1px solid #d4cdeb;border-radius:12px;padding:17px;background:#f7f3ff;box-sizing:border-box;min-width:0;\" class=\"wt-card\"><\/div>\n<\/p><\/div>\n<h2>What Should Traders and Investors Watch Next?<\/h2>\n<ul>\n<li>Sustained delivery volumes relative to the 51.8% delivery rate observed recently<\/li>\n<li>Execution progress and doctor feedback on newly launched specialty products like NeuCeno<\/li>\n<li>Announcements regarding a successor for the outgoing Chief Financial Officer<\/li>\n<\/ul>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<p style=\"background:#f8fafc;border:1px solid #dce5eb;border-left:4px solid #6b7d90;border-radius:9px;padding:14px 16px;\" class=\"wt-copy\"><strong>Catalyst note:<\/strong>No single confirmed company-specific news event drove today&#8217;s decline; the move reflects broader pharmaceutical sector weakness. <\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>What is the likely reason for today&#8217;s move?<\/h3>\n<p class=\"wt-copy\">Alkem&#8217;s 1.65% decline mirrors the broader Nifty Pharma sector downturn of 1.84%. In the absence of adverse company-specific disclosures today, the price movement is best attributed to prevailing sectoral headwinds.<\/p>\n<h3>Is trading volume elevated?<\/h3>\n<p class=\"wt-copy\">Today&#8217;s volume is 142,787. The latest 20-day average available is 144,398, equivalent to about 0.99x of the recent average.<\/p>\n<h3>Before acting on this stock<\/h3>\n<p class=\"wt-copy\">Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review the<a href=\"https:\/\/www.wittytrades.com\/Segments.html\"><strong>WittyTrades subscription plans and research segments<\/strong><\/a>. <\/p>\n<div class=\"witty-related\"><\/div>\n<p><strong>Article by:<\/strong><a href=\"https:\/\/www.wittytrades.com\/About_Us.html\">WittyTrades Research Desk<\/a><\/p>\n<div class=\"witty-disclaimer\"><strong>Disclaimer:<\/strong>Investments in securities markets are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, membership of a supervisory body and certification from NISM do not guarantee performance of the intermediary or provide any assurance of returns to investors. This article is intended for informational and educational purposes and should not be treated as personalised investment advice or a recommendation to buy, sell or hold any security. Market data may be delayed and readers should independently verify current prices and disclosures before taking investment decisions. <\/div>\n<h2>Other Dated Coverage<\/h2>\n<ul class=\"wt-list\">\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/alkem-share-price-today-2026-10-01\/\">Why Alkem Laboratories Shares Fell 2.2% Today: Sector Trends in Focus \u2014 1 October 2026<\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.wittytrades.com\/market-news\/tag\/alkem\/\">More Alkem Laboratories news and dated analysis \u2192<\/a><\/p>\n<\/div>\n<p><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"NewsArticle\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/alkem-share-price-today-2026-09-30\/#article\", \"mainEntityOfPage\": {\"@type\": \"WebPage\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/alkem-share-price-today-2026-09-30\/\"}, \"headline\": \"Why Alkem Laboratories Shares Fell 1.65% Today: Sector Trends | 30 September 2026\", \"description\": \"Alkem Laboratories shares dropped 1.65% amid broader pharma sector weakness. Read about volume trends, recent product launches, and key stock watchpoints.\", \"datePublished\": \"2026-09-30T06:38:13Z\", \"dateModified\": \"2026-10-05T14:43:53.354897+00:00\", \"author\": {\"@type\": \"Organization\", \"name\": \"WittyTrades Research Desk\", \"url\": \"https:\/\/www.wittytrades.com\/About_Us.html\"}, \"publisher\": {\"@type\": \"Organization\", \"name\": \"WittyTrades\", \"url\": \"https:\/\/www.wittytrades.com\/\"}, \"inLanguage\": \"en-IN\", \"image\": [\"https:\/\/www.wittytrades.com\/market-news\/wp-content\/uploads\/2026\/10\/alkem-company-news-2026-09-30.jpg\"]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alkem Laboratories shares dropped 1.65% amid broader pharma sector weakness. Read about volume trends, recent product launches, and key stock watchpoints.<\/p>\n","protected":false},"author":1,"featured_media":3069,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_witty_seo_title":"Why Alkem Laboratories Shares Fell 1.65% Today: Sector Trends | 30 September 2026","_witty_meta_description":"Alkem Laboratories shares dropped 1.65% amid broader pharma sector weakness. Read about volume trends, recent product launches, and key stock watchpoints.","_witty_primary_phrase":"Alkem Laboratories share price 2026-09-30","_witty_reason_label":"Sector-led pullback aligned with broader pharma weakness","_witty_reason_confidence":"medium","footnotes":"","_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_aioseop_title":"","_aioseop_description":""},"categories":[3,4],"tags":[143],"class_list":["post-1057","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-movers","category-stocks-in-news","tag-alkem"],"_links":{"self":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/1057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/comments?post=1057"}],"version-history":[{"count":3,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/1057\/revisions"}],"predecessor-version":[{"id":3072,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/1057\/revisions\/3072"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media\/3069"}],"wp:attachment":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media?parent=1057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/categories?post=1057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/tags?post=1057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}